This nonrandomized clinical trial examines the association of age with survival among Medicare beneficiaries with myelodysplastic syndrome who underwent allogeneic hematopoietic stem cell transplantation.
This multicenter cohort study assesses the association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival among patients with newly diagnosed glioblastoma in different molecular subgroups to develop a new road map for cytoreductive surgery.
This cohort study examines the association between recurrence score and locoregional recurrence in postmenopausal women who received treatment for node-positive, estrogen receptor– or progesterone receptor–positive breast cancer.
This cohort study examines the association between body mass index and survival in patients with non–small cell lung cancer who receive immune checkpoint inhibitor therapy.
This secondary analysis of a randomized clinical trial examines the association between immune-related adverse events and recurrence-free survival among patients with high-risk stage III melanoma who were treated with pembrozimulab therapy or placebo in the EORTC 1325/KEYNOTE-054 study.
This secondary analysis of a randomized clinical trial examines 20-year efficacy and safety outcomes of a large trial of adjuvant high-dose chemotherapy and hematopoietic stem cell transplant (HSCT) vs conventional-dose chemotherapy for patients with stage III breast cancer.
This nonrandomized phase 1/2 clinical trial evaluates the use of trabectedin in combination with low-dose radiotherapy for treating metastatic soft-tissue sarcomas in adult patients.
This population-based cohort study examines the association of germline genetic testing results with locoregional and systemic therapy use in women aged 20 years or older diagnosed with breast cancer.
This study examines the development and outcomes of men with the HSD3B1 genotype receiving treatment for metastatic prostate cancer.
This cohort study compares health care expenditures of patients with chronic myeloid leukemia for first- and second-generation tyrosine kinase inhibitors before and after the transition of imatinib to generic status.
This open-label, multicenter, phase 3 trial conducted in Italy assesses 5-year relapse-free survival to evaluate the noninferiority of 3 months (experimental arm) vs 6 months (control arm) of standard doses of FOLFOX (fluorouracil, leucovorin, and oxaliplatin) or CAPOX (capecitabine plus oxaliplatin) adjuvant chemotherapy in patients with high-risk stage II resected colorectal cancer enrolled in the TOSCA trial.
This pilot cohort study estimates sensitivity and specificity of plasma microbial cell-free DNA sequencing for its ability to predict bloodstream infection in patients at high risk of life-threatening infection.
This cohort study assesses the frequency of abnormal urine drug test findings among patients with cancer pain treated with long-term opioid therapy who underwent random and targeted testing.
This review of stereotactic ablative radiotherapy for spinal metastases contextualizes decisions about optimal multidisciplinary management to help clinicians provide personalized high-quality care for these patients.
A middle-aged woman presented with a tender, pruritic, 4-cm erythematous patch on the forehead that enlarged over the course of 6 weeks. What is your diagnosis?
This Viewpoint exposes the need for environmentally sustainable oncology practices and facilities and evaluates strategies for achieving both.
This Viewpoint discusses limitations of preprints and how they may change oncology practice and research.
This Viewpoint descibes a new proposed US Food and Drug Administration rule that would require graphic warnings for cigarette packages and advertisements and discusses the legality of the rule compared with a previous attempt to implement a similar set of graphic warnings on these products.
This Patient Page describes the use of brachytherapy (internal radiation) for the treatment of cancer and its delivery, adverse effects, and indications.
This article describes an oncologist’s experience engaging in the spiritual lives of a patient with terminal illness and her family.
Create a personal account or sign in to: